AAMS Genetics & Molecular Medicine · Vol. 1 · Issue 4 · 2024-12-05

Pharmacogenomic Predictors of Adverse Drug Reactions in Cardiovascular Therapy

Williams JA, Thompson SR
Department of Clinical Pharmacology, University of Oxford, Oxford, United Kingdom¹; Oxford Centre for Personalized Medicine, Oxford, United Kingdom²
DOI: 10.7759/aams.2024.0038
View on AAMSFull-Text IndexBrowse Articles

Abstract

This study evaluates pharmacogenomic variants in CYP2C19, CYP2D6, and VKORC1 as predictors of adverse drug reactions in 3,200 patients receiving cardiovascular medications, demonstrating significant clinical utility.

Keywords: Pharmacogenomics, Adverse Drug Reactions, Cardiovascular, CYP2C19, Personalized Medicine

Full Text